Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: J Hepatol. 2014 Apr 5;61(2):286–292. doi: 10.1016/j.jhep.2014.03.034

Table 3.

Risk of death associated with reclassification of estimated GFR by measured GFR.

eGFR
ml/min/1.73m2 		Number of
observations		 Reclassification to higher
GFR by mGFR		 No reclassification Reclassification to lower
GFR by mGFR
% of
observations		 HR (95% CI) % of
observations		 HR (95%
CI)		 % of observations HR (95% CI)
≥ 90 352 N/A N/A 57.7% Reference 42.3% 2.25
(0.98–5.21)
60–89 1591 15.6% 0.76
(0.35–1.66)		 60.2% Reference 24.3% 2.37
(1.52–3.68)
45–59 1805 29.3% 0.89
(0.54–1.45)		 46.4% Reference 24.3% 1.70 (1.05–2.74)
30–44 1698 28.2% 0.55
(0.28–1.08)		 547% Reference 17.1% 2.80
(1.83–4.29)
<30 463 31.5% 1.39
(0.60–3. 20 )		 68.5% Reference N/A N/A

HR was adjusted for age and sex